These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26123463)

  • 1. Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.
    Gupta M; Kiruthiga KG
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant mixed müllerian tumor of the uterus following tamoxifen for breast cancer: case report].
    Saim M; Cote JF; Morel O; Malartic C; Akerman G; Gray F; Barranger E
    Gynecol Obstet Fertil; 2008 Feb; 36(2):166-168. PubMed ID: 18249575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant mixed Müllerian tumor of the uterus associated with tamoxifen therapy for breast cancer.
    Magnani KK; Dubey S; Rai S
    Indian J Pathol Microbiol; 2010; 53(4):886-7. PubMed ID: 21045469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

  • 5. Uterine malignant mixed müllerian tumor in a patient on long-term tamoxifen therapy for breast cancer.
    Clarke MR
    Gynecol Oncol; 1993 Dec; 51(3):411-5. PubMed ID: 8112655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
    Behtash N; Hashemi R; Karimi Zarchi M
    Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonography and MRI of tamoxifen-associated müllerian adenosarcoma of the uterus.
    Chourmouzi D; Boulogianni G; Zarampoukas T; Drevelengas A
    AJR Am J Roentgenol; 2003 Dec; 181(6):1673-5. PubMed ID: 14627594
    [No Abstract]   [Full Text] [Related]  

  • 8. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
    Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
    Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine malignant mixed Müllerian tumor after adjuvant tamoxifen treatment for breast cancer.
    Grigoriadis C; Androutsopoulos G; Zygouris D; Arnogiannaki N; Terzakis E
    Eur J Gynaecol Oncol; 2013; 34(1):94-8. PubMed ID: 23590011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen.
    Bouchardy C; Verkooijen HM; Fioretta G; Sappino AP; Vlastos G
    J Clin Oncol; 2002 Nov; 20(21):4403. PubMed ID: 12409344
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
    Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer.
    Curtis RE; Freedman DM; Sherman ME; Fraumeni JF
    J Natl Cancer Inst; 2004 Jan; 96(1):70-4. PubMed ID: 14709741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mixed müllerian tumours of the endometrium. About four cases developed on tamoxifen treatment].
    Le Bouëdec G; Penault-Llorca F; de Latour M; Tortochaux J; Dauplat J
    Gynecol Obstet Fertil; 2003 Sep; 31(9):733-8. PubMed ID: 14499719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary.
    Shi H; Chen X; Lv B; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature.
    Fotiou S; Hatjieleftheriou G; Kyrousis G; Kokka F; Apostolikas N
    Anticancer Res; 2000; 20(3B):2015-20. PubMed ID: 10928144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there any association between uterine malignant mixed Mullerian tumour, breast cancer and prolonged tamoxifen treatment?
    Moe MM; El-Sharkawi S
    J Obstet Gynaecol; 2003 May; 23(3):301-3. PubMed ID: 12850867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2006 Jun; 107(6):1475-8. PubMed ID: 16738185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past!
    Bisu S; Choudhary V
    J Midlife Health; 2018; 9(4):210-211. PubMed ID: 30692818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.